These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15812524)

  • 21. [Hematopoietic cell transplantation in X-linked adrenoleukodystrophy].
    Kato S
    Brain Nerve; 2007 Apr; 59(4):339-46. PubMed ID: 17447520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research.
    Horowitz M
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S1-S2. PubMed ID: 18724277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.
    Bhatia R; Van Heijzen K; Palmer A; Komiya A; Slovak ML; Chang KL; Fung H; Krishnan A; Molina A; Nademanee A; O'Donnell M; Popplewell L; Rodriguez R; Forman SJ; Bhatia S
    J Clin Oncol; 2005 Sep; 23(27):6699-711. PubMed ID: 16170178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual physician practice variation in hematopoietic cell transplantation.
    Lee SJ; Joffe S; Artz AS; Champlin RE; Davies SM; Jagasia M; Kernan NA; Loberiza FR; Soiffer RJ; Eapen M
    J Clin Oncol; 2008 May; 26(13):2162-70. PubMed ID: 18378566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Bone Marrow Transplant; 2006 Feb; 37(3):249-61. PubMed ID: 16435004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second malignancies after allogeneic hematopoietic cell transplantation.
    Lowe T; Bhatia S; Somlo G
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1121-34. PubMed ID: 17889348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.
    Perkins JL; Kunin-Batson AS; Youngren NM; Ness KK; Ulrich KJ; Hansen MJ; Petryk A; Steinberger J; Anderson FS; Baker KS
    Pediatr Blood Cancer; 2007 Dec; 49(7):958-63. PubMed ID: 17474113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.
    Miano M; Labopin M; Hartmann O; Angelucci E; Cornish J; Gluckman E; Locatelli F; Fischer A; Egeler RM; Or R; Peters C; Ortega J; Veys P; Bordigoni P; Iori AP; Niethammer D; Rocha V; Dini G;
    Bone Marrow Transplant; 2007 Jan; 39(2):89-99. PubMed ID: 17213848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic cell transplantation for Chediak-Higashi syndrome.
    Eapen M; DeLaat CA; Baker KS; Cairo MS; Cowan MJ; Kurtzberg J; Steward CG; Veys PA; Filipovich AH
    Bone Marrow Transplant; 2007 Apr; 39(7):411-5. PubMed ID: 17293882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell transplantation in Europe: trends and prospects.
    Tan SS; Uyl-de Groot CA; Huijgens PC; Fibbe WE
    Eur J Cancer; 2007 Nov; 43(16):2359-65. PubMed ID: 17919900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias.
    Niederwieser D; Gentilini C; Hegenbart U; Lange T; Becker C; Wang SY; Bartsch K; Pönisch W; Raida M; Al-Ali H
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):275-81. PubMed ID: 16213741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplantation in inborn errors of metabolism: current considerations and future perspectives.
    Boelens JJ; Orchard PJ; Wynn RF
    Br J Haematol; 2014 Nov; 167(3):293-303. PubMed ID: 25074667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current trends in hematopoietic stem cells therapeutic use].
    Espérou H
    Rev Prat; 2008 Dec; 58(19):2130-6. PubMed ID: 19213541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center.
    Ringdén O; Remberger M; Svahn BM; Barkholt L; Mattsson J; Aschan J; Le Blanc K; Gustafsson B; Hassan Z; Omazic B; Svenberg P; Solders G; von Döbeln U; Winiarski J; Ljungman P; Malm G
    Transplantation; 2006 Mar; 81(5):718-25. PubMed ID: 16534474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
    Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolution of hematopoietic SCT in myelodysplastic syndrome.
    Kindwall-Keller T; Isola LM
    Bone Marrow Transplant; 2009 Apr; 43(8):597-609. PubMed ID: 19252532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program.
    Bolan CD; Hartzman RJ; Perry EH; Trainor L; Miller J; Miller R; Hanley L; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):23-8. PubMed ID: 18721777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.